AXGN logo
AxoGen, Inc.(AXGN)
Last print unknown agoAbout this dataData status
$35.24▲0.62 (1.79%)Stale · unknown oldEarnings · Oct 28

AXGN Total Liabilities

$48.61MQuarterly · USD

Period ending:

AXGN FY Total LiabilitiesUSD
AXGN FY Total Liabilities1987-06-30: $1.30M1988-06-30: $1.10M1989-06-30: $51.60M1990-06-30: $1.50M1991-06-30: $700.00K1992-06-30: $700.00K1993-06-30: $700.00K1994-06-30: $1.70M1995-06-30: $1.50M1996-06-30: $1.40M1997-06-30: $3.00M1998-06-30: $2.20M1999-06-30: $2.70M2001-06-30: $3.75M2001-12-31: $2.81M2002-12-31: $3.18M2003-12-31: $2.84M2004-12-31: $521.05K2005-12-31: $160.86K2006-12-31: $217.87K2007-12-31: $201.17K2008-12-31: $211.06K2009-12-31: $5.75M2010-12-31: $114.35K2011-12-31: $6.42M2012-12-31: $23.06M2013-12-31: $27.55M2014-12-31: $27.65M2015-12-31: $29.35M2016-12-31: $31.44M2017-12-31: $33.69M2018-12-31: $13.19M2019-12-31: $22.49M2020-12-31: $78.23M2021-12-31: $95.47M2022-12-31: $94.39M2023-12-31: $101.16M2024-12-31: $99.82M2025-12-31: $92.84M$101.16M$0.00
1987-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AXGN total liabilities history

Total amount the company owes to creditors. The available annual fiscal periods series contains 39 observations from Jun 30, 1987 to Dec 31, 2025.

Axogen Inc Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)
92,840,000
99,821,000
101,162,000
94,388,000
95,474,000
78,232,000
22,490,000
13,191,000
33,692,663
31,439,329
29,350,462
27,646,469
27,547,637
23,060,004
6,423,571
114,349
5,747,266
211,056
201,174
217,874
160,860
521,052
2,844,418
3,183,408
2,809,955
3,754,733
2,700,000
2,200,000
3,000,000
1,400,000
1,500,000
1,700,000
700,000
700,000
700,000
1,500,000
51,600,000
1,100,000
1,300,000

Compare total liabilities

All AXGN financial metrics · AXGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.